National Bank of Canada’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27K | Buy |
2,300
+900
| +64% | +$887 | ﹤0.01% | 2245 |
|
|
2025
Q1 | $2.02K | Sell |
1,400
-1,050
| -43% | -$1.51K | ﹤0.01% | 2181 |
|
|
2024
Q4 | $5.39K | Sell |
2,450
-6,200
| -72% | -$13.6K | ﹤0.01% | 2063 |
|
|
2024
Q3 | $14.3K | Sell |
8,650
-10,400
| -55% | -$17.2K | ﹤0.01% | 1820 |
|
|
2024
Q2 | $44.2K | Buy |
19,050
+10,225
| +116% | +$23.7K | ﹤0.01% | 1585 |
|
|
2024
Q1 | $19.3K | Buy |
+8,825
| New | +$19.3K | ﹤0.01% | 1845 |
|
|
2023
Q2 | – | Sell |
-10,446
| Closed | -$16.6K | – | 2574 |
|
|
2023
Q1 | $16.6K | Sell |
10,446
-96
| -0.9% | -$153 | ﹤0.01% | 1882 |
|
|
2022
Q4 | $65.7K | Sell |
10,542
-376
| -3% | -$2.34K | ﹤0.01% | 1518 |
|
|
2022
Q3 | $73K | Sell |
10,918
-177
| -2% | -$1.18K | ﹤0.01% | 1438 |
|
|
2022
Q2 | $70K | Sell |
11,095
-137
| -1% | -$864 | ﹤0.01% | 1473 |
|
|
2022
Q1 | $52K | Sell |
11,232
-1,077
| -9% | -$4.99K | ﹤0.01% | 1633 |
|
|
2021
Q4 | $61K | Buy |
+12,309
| New | +$61K | ﹤0.01% | 1579 |
|